{"entity":{"type":"insider","cik":"0001793412","url":"/insider/0001793412","json_url":"/insider/0001793412.json","name":"Alam Kamran","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2021-08-20","last":"2026-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Alam Kamran","source":"filing","n_filings":7,"first_seen":"2021-08-20","last_seen":"2026-02-06"}],"transactions":[{"id":5779266,"accession":"0001793412-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001793412-26-000012","line_url":"/filing/0001793412-26-000012#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1655.0,"shares_display":"1,655","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":7480.6,"total_display":"7,480.60","total_whole":"7,481","shares_owned_after":1442131.0,"shares_owned_after_display":"1,442,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":5789194,"accession":"0001793412-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001793412-26-000008","line_url":"/filing/0001793412-26-000008#line-2","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23849.0,"shares_display":"23,849","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":109943.89,"total_display":"109,943.89","total_whole":"109,944","shares_owned_after":1443786.0,"shares_owned_after_display":"1,443,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider"},{"id":5789192,"accession":"0001793412-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001793412-26-000008","line_url":"/filing/0001793412-26-000008#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78968.0,"shares_display":"78,968","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":375098.0,"total_display":"375,098.00","total_whole":"375,098","shares_owned_after":1467635.0,"shares_owned_after_display":"1,467,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-27","scope":"insider"},{"id":4147000,"accession":"0001415889-25-022749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022749","line_url":"/filing/0001415889-25-022749#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54491.0,"shares_display":"54,491","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":155299.35,"total_display":"155,299.35","total_whole":"155,299","shares_owned_after":1187603.0,"shares_owned_after_display":"1,187,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":8470379,"accession":"0001209191-23-047323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047323","line_url":"/filing/0001209191-23-047323#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":76890.0,"total_display":"76,890.00","total_whole":"76,890","shares_owned_after":258042.0,"shares_owned_after_display":"258,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider"},{"id":6374151,"accession":"0001209191-22-047353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047353","line_url":"/filing/0001209191-22-047353#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3325.0,"shares_display":"3,325","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":11537.75,"total_display":"11,537.75","total_whole":"11,538","shares_owned_after":266121.0,"shares_owned_after_display":"266,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-24","scope":"insider"},{"id":6729527,"accession":"0001209191-22-047097","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-047097","line_url":"/filing/0001209191-22-047097#line-3","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9717.0,"shares_display":"9,717","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":34009.5,"total_display":"34,009.50","total_whole":"34,010","shares_owned_after":269446.0,"shares_owned_after_display":"269,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-22","scope":"insider"},{"id":6729524,"accession":"0001209191-22-047097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-047097","line_url":"/filing/0001209191-22-047097#line-2","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11482.0,"shares_display":"11,482","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":43057.5,"total_display":"43,057.50","total_whole":"43,058","shares_owned_after":279163.0,"shares_owned_after_display":"279,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-22","scope":"insider"},{"id":6729521,"accession":"0001209191-22-047097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047097","line_url":"/filing/0001209191-22-047097#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7476.0,"shares_display":"7,476","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":28932.12,"total_display":"28,932.12","total_whole":"28,932","shares_owned_after":290645.0,"shares_owned_after_display":"290,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-22","scope":"insider"},{"id":4142254,"accession":"0001209191-21-052824","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-052824","line_url":"/filing/0001209191-21-052824","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11840.0,"shares_display":"11,840","price_per_share":16.777817567567567,"price_display":"16.78","price_state":"stated","total_value":198649.36,"total_display":"198,649.36","total_whole":"198,649","shares_owned_after":300215.0,"shares_owned_after_display":"300,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-20","scope":"insider","n_lines":2},{"id":4142247,"accession":"0001209191-21-052824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-052824","line_url":"/filing/0001209191-21-052824","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9967.0,"shares_display":"9,967","price_per_share":16.471822012641717,"price_display":"16.47","price_state":"stated","total_value":164174.65,"total_display":"164,174.65","total_whole":"164,175","shares_owned_after":310574.0,"shares_owned_after_display":"310,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider","n_lines":2},{"id":4142240,"accession":"0001209191-21-052824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052824","line_url":"/filing/0001209191-21-052824#line-1","is_derivative":false,"issuer_cik":"0001793412","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001793412","owner_cik":"0001793412","owner_name":"Alam Kamran","owner_display_name":"Alam Kamran","owner_url":"/insider/0001793412","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11193.0,"shares_display":"11,193","price_per_share":17.35,"price_display":"17.35","price_state":"stated","total_value":194198.55,"total_display":"194,198.55","total_whole":"194,199","shares_owned_after":319928.0,"shares_owned_after_display":"319,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806310","name":"Taysha Gene Therapies, Inc.","url":"/issuer/0001806310","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":7,"first_seen":"2021-08-20","last_seen":"2026-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001793412","retrieved_at":"2026-08-25T04:58:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}